A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Pfizer gets obesity drug approval in China shortly after buying local rights
Pfizer gets obesity drug approval in China shortly after buying local rights
Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push
Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push
Nektar posts one-year eczema success; Pfizer ends malnutrition trial
Nektar posts one-year eczema success; Pfizer ends malnutrition trial
The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Pfizer to depart GSK's ViiV as Shionogi doubles its stake
Pfizer to depart GSK's ViiV as Shionogi doubles its stake
At FDA's request, Pfizer helps ease shortage of potential autism drug
At FDA's request, Pfizer helps ease shortage of potential autism drug
French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
Updated: Pfizer discloses patient death in Hympavzi hemophilia trial
Up­dat­ed: Pfiz­er dis­clos­es pa­tient death in Hym­pa­vzi he­mo­phil­ia tri­al A pa­tient in Pfiz­er’s tri­...
Pfizer bets big on obesity to offset major patent cliff
Pfizer bets big on obesity to offset major patent cliff
OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen
Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen
Pfizer-allied molecular glue startup Triana collects $120M Series B
Patrick Trojer, Triana Biomedicines CEO December 3, 2025 10:28 AM EST Updated 12:23 PM FinancingStartups Pfizer-allied molecular glue startup collects 20M Seri...
Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug
December 2, 2025 10:46 AM EST News Briefing Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug ENDPOINTS Plus, news about Jasper,...
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page